Patients with a recurrence of head and neck cancer who have previously received radiation treatment can be treated more quickly, safely and with fewer side effects with high doses of targeted radiation known as Stereotactic ...
Sep 17, 2014
0
0
A new study shows that patients with human papillomavirus (HPV) – the same virus associated with both cervical and head and neck cancer – positive oropharyngeal cancer see significantly higher rates of complete response ...
Sep 17, 2014
0
0
Imagine you're fighting for your life but no matter how hard you hit, your opponent won't go down.
Jul 31, 2014
0
0
Diabetes mellitus (DM) appears to increase the risk for head and neck cancer (HNC). Evidence suggests certain cancers are more common in people with DM, but the risk of HNC in patients with DM has not been well explored. ...
Jul 24, 2014
0
0
(Medical Xpress)—Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to researchers ...
Jun 26, 2014
0
0
Case Western Reserve University School of Dental Medicine and the Department of Otolaryngology at University Hospitals Case Medical Center will collaborate on a pilot study to examine whether an abundance of naturally occurring ...
Jun 16, 2014
0
0
Public awareness of head and neck cancer (HNC) is low, with few Americans knowing much about risk factors such as tobacco use and human papillomavirus (HPV).
Jun 5, 2014
0
0
The national survival rates for African-Americans diagnosed with head and neck cancer have not improved in the last 40 years despite advances in the treatment and management of the disease, University of Missouri School of ...
Jun 5, 2014
0
0
A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers.
Apr 8, 2014
0
0
Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN), the most common form of head and neck cancer, may benefit from treatment with the investigational drug dacomitinib if their cancer ...
Apr 8, 2014
0
0
